식품유래 곰팡이 대사산물의 항암효과

Inhibitory Effects of Fungal Metabolites Isolated from Foodstuffs on the Growth of Human Cancer Cell Lines

  • 임효권 (계명대학교 식품가공학 전공) ;
  • 유미희 (계명대학교 식품가공학 전공) ;
  • 정덕화 (경상대학교 응용생명과학부) ;
  • 이인선 (계명대학교 전통미생물자원개발 및 산업화연구(TMR) 센터)
  • Im, Hyo-Gwon (Department of Food Science and Technology, Keimyung University) ;
  • Yu, Mi-Hee (Department of Food Science and Technology, Keimyung University) ;
  • Chung, Duck-Wha (Division of Applied Life Science, Gyeongsang National University) ;
  • Lee, In-Seon (The Center for Traditional Microorganism Resources, Keimyung University)
  • 발행 : 2006.04.01

초록

본 논문은 새로운 항암소재를 검색하기 위하여 식품으로부터 곰팡이를 분리하고 그 대사산물을 이용하여 수종의 암세포주의 생육을 대한 억제 물질을 탐색하고자 하며, 이를 바탕으로 새로운 항생물질 연구의 기초자료를 확보하고 결과물의 응용도를 모색하고자 실험을 수행하였다. 식품으로부터 총 72종의 곰팡이를 분리 하였고, 전면 및 후면의 색, 모양. 성장속도에 따라 4가지 group로 나누어 실험에 사용하였다. 그리고 그 대사산물(배양무, 균체)을 ethly acetate로 추출하여, 총 6종의 암세포주에 대하여 MTT assay을 실험하였다. 그 ruf과 A, B, C, D group 중 D group에서 가장 높은 증식 억제를 확인 하였으며, D4의 증식억제 효과가 가장 높음을 확인하였다. 위암 세포주인 KATO III, AGS, SUN-668에 대한 증식억제 효과는 30-98%로 나타났으며, 간암 세포주인 Hepa1c1c7, HepG2에는 10-98%, 유방암 세포주인 MDA-MB-231에 대해서는 25-90%의 증식억제 효과를 확인하였다. 배양물과 균체의 항암성은 개체에 따라 약간의 차이는 있으나, 배양물이 대부분 우수한 것으로 확인되었다.

Inhibitory effects of fungal metabolites isolated from foodstuffs on growth of human cancer cell lines were evaluated. Isolated strains were divided into four classes based on color (aerial, reverse), shape, and growth speed. Fungal metabolites extracted with ethyl acetate were investigated for their growth inhibition on six kinds of human cancer cells by MTT assay. Ethyl acetate extract showed high growth inhibition against all cancer cells tested, with D4 exhibiting the strongest growth inhibition effects against Kato III, AGS, Hepa1c1c7, and MDA-MB-231 cancer cells. These results suggest ethyl acetate extract from fungal metabolites as effective natural cancer therapeutic material.

키워드

참고문헌

  1. Folkman J. Role or angiogenesis in tumor growth and matastasis. Semin Oncol. 29: 15-18 (2002) https://doi.org/10.1053/sonc.2002.37263
  2. Ashendel CL. Diet, signal transduction and carcinogenesis. J Nutr. 125: 686-691 (1995)
  3. Doll R, Peto R. The causes of cancer. J. Natl. Cancer Inst. 66: 1191-1308 ( 1981)
  4. Wynder EL. Gori G. Contribution or the environment to cancer incidence: an epidemiologic exercise. J. Natl. Cancer lust. 58: 825-832 (1977) https://doi.org/10.1093/jnci/58.4.825
  5. Wakabayashi K, Nagao M, Esumi H, Sugimura T. Food-derived mutagens and carcinogens. Cancer Res. 52: 2092-2098 (1992)
  6. Wattenberg LW. Inhibition of carinogenesis by minor dietary constituents. Cancer Res. 5: 2985-2091 (1992)
  7. Kellof GJ, Boone CW, Crowell JA. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prev. 3: 85-88 (1994)
  8. Kada T, Inoue T, Morita K, Namiki M. Dietary desmutagens. pp. 245-253. In: Genetic Toxicology of the Diet. Knudesn. I. (ed). Alan R. Liss Inc., New York, NY, USA (1986)
  9. Ronald RW, Siraj IM. A synopsis causes and prevention strategies. pp. 1-12. In: Nutrition and Cancer Prevention. Ira W (ed). CRC Press, Inc., Boca Raton, FL, USA (2000)
  10. Clifford C, Kramer B. Diet as risk and therapy for cancer. Med. Clin. North Am. 77: 725-744 (1993) https://doi.org/10.1016/S0025-7125(16)30220-6
  11. Fleming A. On the antibacterial action of a Penicillium with special reference to their use in the isolation of B. influenza. Brit. J. Exp. Pathol. 10: 226-236 (1929)
  12. dubos RJ. Bacteriocidal effect of an extract of a soil Bacillus on Gram positive cocci. Proc. Soc. Exp. Bio. Med. 40: 311-317 (1939)
  13. Berdy J. The discovery of new bioactive microbial metabolites: Screening and identification. Elsevier, pp. 3-25 (1989)
  14. Pitt JI, Hocking AD. Fungi and Food Spoilage. second eds. Printed in Great Britain at the University Press, Cambridge, London. UK. 149-180(1997)
  15. Mosmann T. Rapid colometic assy for cellular growth survival: Application to proliferation and cytotoxicity assays. J. lmmunol. Methods 65: 55-63 (1983) https://doi.org/10.1016/0022-1759(83)90303-4
  16. Sakaguchi K, Nakajima H, Mizuta N, Furukawa C, Ozawa S, Ando K, Chang YC, Yamagishi H, Magae J. Selective cytotoxicity of ascochlorin in ER-negative human breast cancer cell lincs. Biochem. Biophys. Res. Commun. 39: 46-50 (2005) https://doi.org/10.1016/0006-291X(70)90755-2
  17. Giannini G, Penco S, Pisano C, Riccioni T, Nasini G, Candiani G. Chrysanthones, a new source of fungal metabolites with potential antimor and antiangiogenesis properties. Fitoterapia 74: 323-327 (2003) https://doi.org/10.1016/S0367-326X(03)00059-5
  18. Lee IS, Nishikawa A. Polvzellus multiplex, a Korean wild mushroom, as a potent chemopreventive agent against stomach cancer. Life Sci. 73: 3225-3234, (2003) https://doi.org/10.1016/j.lfs.2003.06.006
  19. Ha YD. Antitumoral, antioxidant and antimicrobial activities of solvent fractions from Grifola umbellatus. Korean J. Postharvest Sci. Technol. 8: 481-487 (2001)
  20. Bea JT, Chang JS, Lee KR. Effect of sarcodon aspratus extract on expression of cell cycle-associated proteins in HepG2 cells. J. Korean Soc. Food Sci. Nutr. 31: 329-332 (2002) https://doi.org/10.3746/jkfn.2002.31.2.329
  21. Ham SS, Chung CK, Lee JH, Choi KP, Jung SW, Kim EJ. Antimutagenicity and cytotoxicity of crtemisia iwayomogi kitamura extracts. J. Korean Soc. Food Sci. Nutr. 27: 157-162 (1998)
  22. Sung MK, Park MY. Cytotoxic and apoptotic Effects of soybean and brown rice extracts on hormone dependent/independent breast cancer cell lines. J. Korean Soc. Food Sci. Nutr. 31: 521-526 https://doi.org/10.3746/jkfn.2002.31.3.521